Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStatPro Regulatory News (SOG)

  • There is currently no data for SOG

Director/PDMR Shareholding

30 Mar 2011 16:25

RNS Number : 9483D
Statpro Group PLC
30 March 2011
 



 

 

For immediate release 30 March 2011

 

STATPRO GROUP PLC

("StatPro" or the "Group")

 

Directors' dealings

Exercise and Net settlement of Share Options

 

Grant of options

StatPro Group plc (AIM:SOG), the AIM listed provider of portfolio analytics and data solutions for the global asset management industry, today announces the grant of share options over a total of 600,000 ordinary shares of 1p each in the Company ("Ordinary Shares") to directors and senior employees in the Group.

 

The options are exercisable at 130p per share being a premium of 10% over the closing mid-market share price of 118p per Ordinary Share on 29 March 2011. Exercise of the options is conditional upon the satisfaction of performance conditions. The options will not be exercisable unless the share price equals or exceeds 145p per share for a period of at least twenty consecutive trading days and specified targets of growth in earnings per share are met. The share options are exercisable at any time between 29 March 2014 and 29 March 2018 being a period of between three years and seven years from the date of grant, subject to the satisfaction of the performance conditions.

 

The grants of options include grants to StatPro's executive directors over the following numbers of shares:

 

Justin Wheatley, Chief Executive 35,000

Andrew Fabian, Finance Director 35,000

 

Exercise and Net settlement of Share Options

Following the receipt by the Company of applications relating to the exercise of options over 140,583 shares at exercise prices of 60p or 61p under Company share option schemes, the Company has opted to net settle 74,500 options by cash settlement in order to reduce the impact of dilution. The net settlement value was determined by the Board as 118p per ordinary share. As a result, cash amounting to a total of approximately £43,000 including option tax liability has been paid and 66,083 shares have been issued. Application has been made for the admission to AIM of 66,083 new Ordinary Shares. It is expected that dealings will commence on 5 April 2011. These shares will rank pari passu with the Group's existing issued Ordinary Shares.

 

Within this total, Andrew Fabian, Finance Director, exercised on 29 March 2011 35,000 options at 60p per share and subsequently sold 35,000 shares today at 116.4p per share from his SIPP resulting in no beneficial change to his holdings.

 

Other director dealings

The Company was informed today that on 29 March 2011 Mark Adorian, Non-Executive Director, purchased 120,000 Ordinary Shares and his wife sold 120,000 Ordinary Shares at 118p per share resulting in no beneficial change to his holdings.

 

The Company was informed today that Charles Fairbairn, Non-Executive Director, purchased 24,400 Ordinary Shares today in his SIPP at 117.5p per share and sold today 24,400 Ordinary Shares in his own name at 117.5p per share resulting in no beneficial change to his holdings.

 

Following these allocations and transactions Justin Wheatley is interested in 7,159,367 Ordinary Shares representing approximately 11.78% of the Company's issued ordinary share capital and options over 1,170,000 Ordinary Shares. Andrew Fabian is interested in 207,795 Ordinary Shares representing approximately 0.34% of the Company's issued Ordinary Share capital and options over 182,000 Ordinary Shares. Mark Adorian is interested in 2,520,698 Ordinary Shares representing approximately 4.15% of the Company's issued Ordinary Share capital. Charles Fairbairn is interested in 779,834 Ordinary Shares representing approximately 1.28% of the Company's issued Ordinary Share capital.

 

Voting rights

Following Admission, the Company's enlarged issued share capital will comprise 60,793,315 Ordinary Shares with voting rights and the Company holds 225,000 shares in treasury. This figure of 60,793,315 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

- Ends -

 

For further information, please contact:

 

StatPro Group plc

www.statpro.com

Justin Wheatley, Chief Executive

020 8410 9876

Andrew Fabian, Finance Director

 

Cenkos Securities

Ken Fleming (NOMAD)

0131 220 6939

Jon Fitzpatrick (NOMAD)

0207 397 8900

Julian Morse (Broker)

020 7397 1931

Threadneedle Communications

Caroline Evans-Jones/ Tom Moriarty/ Hilary Millar

 

020 7653 9850

 

About StatPro

StatPro is a leading provider of portfolio analytics and data solutions for the global asset management industry. The Company sells a SaaS-based Analytics and Data platform on a rental basis to investment management companies allowing them to analyse portfolio performance, attribution, risk and GIPS® compliance. StatPro also provides market data and valuation feeds including a Complex Asset Pricing service.

StatPro has grown its recurring revenue from less than £1 million in 1999 to £29 million at end December 2010 and currently enjoys a renewal rate of approximately 92%. StatPro floated on the London Stock Exchange in May 2000 and transferred its listing in June 2003 to AIM. The Company has operations in Europe, North America, South Africa and Australia, with approximately 79% of recurring revenues being generated outside the UK.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSDUFISFFSEFD
Date   Source Headline
21st Feb 20087:00 amRNSAcquisition
18th Jan 20087:00 amRNSYear End Trading Update
21st Dec 200710:55 amRNSAdditional Listing
19th Dec 20077:01 amRNSDirector/PDMR Shareholding
14th Dec 20079:37 amRNSHolding(s) in Company
30th Nov 20079:48 amRNSAdditional Listing
22nd Nov 200710:12 amRNSDirector/PDMR Shareholding
8th Nov 20074:22 pmRNSDirector/PDMR Shareholding
19th Oct 20077:00 amRNSTrading Update
28th Sep 20073:49 pmRNSDirector/PDMR Shareholding
14th Sep 200710:40 amRNSAdditional Listing
21st Aug 200711:47 amRNSHolding(s) in Company
16th Aug 20073:57 pmRNSAIM Rule 26 Compliant Website
1st Aug 20079:00 amRNSDirector/PDMR Shareholding
30th Jul 20077:01 amRNSAcquisition
30th Jul 20077:01 amRNSInterim Results
12th Jul 20077:00 amRNSHalf Year Trading Update
5th Jun 20079:53 amRNSDirector/PDMR Shareholding
21st May 20079:13 amRNSDirector/PDMR Shareholding
16th May 20077:01 amRNSAGM Statement
10th May 20073:48 pmRNSHolding(s) in Company
10th May 20073:41 pmRNSHolding(s) in Company
30th Apr 200710:05 amRNSTotal Voting Rights
20th Apr 20072:53 pmRNSDirector/PDMR Shareholding
18th Apr 20074:03 pmRNSAnnual Report and Accounts
17th Apr 20072:47 pmRNSHolding(s) in Company
13th Apr 20079:00 amRNSAdditional Listing
12th Apr 20079:39 amRNSDirector/PDMR Shareholding
11th Apr 20075:37 pmRNSDirector/PDMR Shareholding
30th Mar 200712:00 pmRNSAdditional Listing
29th Mar 200710:03 amRNSTotal Voting Rights
22nd Mar 20079:44 amRNSHolding(s) in Company
19th Mar 20073:55 pmRNSAdditional Listing
16th Mar 200712:43 pmRNSHolding(s) in Company
12th Mar 20077:03 amRNSFinal Results
29th Jan 20072:18 pmRNSTotal Voting Rights
18th Jan 20072:33 pmRNSAdditional Listing
18th Jan 20077:01 amRNSTrading Statement
21st Dec 200611:53 amRNSTotal Voting Rights
21st Dec 200611:50 amRNSExercise of Option Agreement
19th Dec 20062:21 pmRNSAdditional Listing
4th Dec 20064:36 pmRNSAdditional Listing
30th Nov 20063:03 pmRNSDirector/PDMR Shareholding
7th Nov 200612:01 pmRNSAdditional Listing
27th Oct 20062:19 pmRNSHolding(s) in Company
25th Oct 20064:49 pmRNSDirector/PDMR Shareholding
17th Oct 200612:45 pmRNSHolding(s) in Company
2nd Oct 20063:41 pmRNSAdditional Listing
28th Sep 20062:45 pmRNSCircular Posted
27th Sep 20067:03 amRNSAcquisition & Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.